Clinical Trial

The Impact of Irrisept in Reducing Urinary Tract Infection During Urethral Catheter Removal.

Recruiting
View on ClinicalTrials.gov →
Summary
Given the high burden of post-catheter removal UTIs, this study aims to evaluate Irrisept instillation as a non-antibiotic intervention to reduce infection rates. By comparing Irrisept to saline irrigation, the study will provide critical insights into the efficacy of antiseptic bladder irrigation in preventing UTIs while minimizing antibiotic use. If successful, this approach could lead to new clinical guidelines for catheter removal protocols, improving patient outcomes and reducing healthcare costs.
Trial Details
NCT Number NCT07239219
Lead Sponsor Ohio State University
Collaborators: Irrimax Corporation
Conditions Urinary Tract Infection, Antibiotic, Catheter Infection
Enrollment 300 participants
Start Date 2026-01-01
Primary Completion 2028-01-01 (estimated)
Study Completion 2028-01-01 (estimated)
Updated on ClinicalTrials.gov 2026-07-31